Raymond James Financial Services Advisors, Inc. - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 36 filers reported holding AIM IMMUNOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q4 2022$11,525
-47.6%
36,9500.0%0.00%
Q3 2022$22,000
-24.1%
36,950
-1.3%
0.00%
Q2 2022$29,000
-35.6%
37,450
-22.7%
0.00%
Q4 2021$45,000
-54.1%
48,4500.0%0.00%
Q3 2021$98,000
-4.9%
48,450
+1.0%
0.00%
Q2 2021$103,00047,9500.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q1 2023
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders